Back to search
Gynecologic Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Gynecologic Cancer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Gynecologic Cancer trials you may qualify forThis phase II ComboMATCH treatment trial compares the effect of neratinib to the combination of neratinib and palbociclib in treating patients with HER2 positiv…
Phase 1/2, open-label study of ETX-636 in participants with advanced solid tumors
This observational study aims to gather comprehensive data on primary ovarian leiomyosarcoma (POLMS). This extremely rare malignancy accounts for less than 3% o…
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients w…
Background: Gynecologic conditions are those that are related to the reproductive system. They can be reproductive gland disorders or reproductive system tumor…
The aim of this study is to lay the bases for an ambitious project that reports and records all the epidemiological-clinical information of the cases of endomet…
Background: More than 75% of women with cancer experience taste disorders during adjuvant chemotherapy. Bitter phantogeusia is particularly limiting. This can l…
This study will develop a blood test that can be used to predict a relapse of ovarian, peritoneal, or fallopian tube cancer. The type of testing is called prote…
This study, organized by the European Society of Gynaecological Oncology (ESGO), evaluates the clinical impact of adherence to ten ESGO-established quality indi…